Related Experiment Video

Updated: May 31, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Pro-oncogenic cell signaling machinery as a target for oncolytic viruses

Emma Borrego-Diaz1, Rajesh Mathew, Dana Hawkinson

  • 1Molecular Medicine Laboratory, Department of Medicine, The University of Kansas Medical Center, Kansas City,Kansas 66160, USA.

Current Pharmaceutical Biotechnology
|July 12, 2011
PubMed

Insights

Oncolytic viruses are engineered to exploit cancer cell signaling pathways, like Ras signaling, for targeted therapy. This review explores viruses designed for specificity against pro-oncogenic characteristics, improving cancer treatment strategies.

Area of Science:

  • Virology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Viruses interact with host cell signaling pathways for replication.
  • Oncolytic viruses leverage these interactions for cancer treatment.
  • Targeting pro-oncogenic signaling is key for next-generation oncolytic viruses.

Purpose of the Study:

  • To review the development of oncolytic viruses targeting specific cancer signaling pathways.
  • To highlight the importance of Ras signaling in oncolytic virus design.
  • To explore strategies for creating viruses with specificity for cancer cell characteristics.

Main Methods:

  • Review of existing literature on oncolytic viruses and cancer signaling.
  • Analysis of viral mechanisms for engaging host cell machinery.
  • Case studies of oncolytic herpes viruses targeting Ras signaling.

Main Results:

  • Oncolytic viruses can be rationally designed to target cancer-specific signaling pathways.
  • Ras signaling is a critical target for developing effective oncolytic viruses.
  • Viral specificity for pro-oncogenic features enhances therapeutic potential.

Conclusions:

  • Exploiting host cell signaling, particularly Ras pathways, is crucial for oncolytic virus efficacy.
  • Developing viruses with tailored specificity offers a promising strategy for cancer therapy.
  • Future oncolytic virus development should focus on precise targeting of cancer-promoting molecular mechanisms.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...